Olga Ornatsky is a Soviet born, Canadian scientist. Ornatsky co-founded DVS Sciences in 2004 (acquired by Fluidigm in 2014 and then renamed to Standard BioTools in 2022) along with Dmitry Bandura, Vladimir Baranov and Scott D. Tanner.
Biography Ornatsky graduated from the Moscow State University, Department of Biology. In 1989, she completed her Ph.D. in cell and molecular biology, and worked as a research scientist at the Cardiology Centre studying vascular smooth muscle involvement in atherosclerosis. In 1993, she immigrated to Canada, and became a postdoctoral research fellow at York University. She quickly progressed to become senior research associate in the Laboratory of Vascular Biology and Cardiac Surgery at St. Michael's Hospital (Toronto). Her achievements brought her to MDS Proteomics Inc. (now Protana Inc), where she led her research group as a senior scientist for four years. In 2005, she left MDS to pursue a different direction. Together with the co-founders of DVS Sciences Inc. Scott D. Tanner, Vladimir Baranov and Dmitry Bandura, she helped develop the CyTOF™ Mass Cytometer, for highly multi-parametric single cell analysis at the Department of Chemistry, University of Toronto. Olga held the position of director of Bioassay Development at DVS Sciences, Inc. After the merger with Fluidigm Inc in 2014, she transitioned to principal scientist, Proteomics division, and led a group of biology and chemistry researchers involved in developing new metal-tagged affinity reagents, as well as methods and applications for Mass cytometry until her retirement in 2019.
Education M.Sc. in biology Moscow State University Ph.D. in cell and molecular biology Moscow State University- In 1989
Career Research scientist in cardiology at Moscow State University Postdoctoral research fellow at York University - 1993 Senior research associate, Laboratory of Vascular Biology and Cardiac Surgery at St. Michael's Hospital (Toronto) Senior scientist MDS Proteomics, Inc. - 2001- 2005 Research associate, Institute of Biomaterials and Biomedical Engineering (IBBME), University of Toronto Principal scientist, biology DVS Sciences - 2005 - 2019 (acquired by Fluidigm in 2014 and then Standard BioTools in 2022)
Research Ornatsky has more than fifteen years of experience in the commercial environment as a senior strategic product application developer and in providing advanced customer/collaborator support. Her primary field of expertise is in cellular and molecular biology, with the objective of developing bioanalytical assays for mass cytometry(CyTOF). Olga is a principal inventor on several patents.
Awards and honors 2019 HUPO Award (Human Proteome Organization)
Publications
… excerpt ends here. Continue reading the full article.


